147 related articles for article (PubMed ID: 7004350)
1. Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics.
Goldstein EJ; Gombert ME; Agyare EO
Antimicrob Agents Chemother; 1980 Nov; 18(5):832-3. PubMed ID: 7004350
[TBL] [Abstract][Full Text] [Related]
2. Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents.
Goldstein EJ; Cherubin CE; Corrado ML; Sierra MF
Rev Infect Dis; 1982; 4 Suppl():S406-10. PubMed ID: 6294791
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Eikenella corrodens to ten cephalosporins.
Goldstein EJ; Sutter VL; Finegold SM
Antimicrob Agents Chemother; 1978 Oct; 14(4):639-41. PubMed ID: 363054
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Eikenella corrodens to thirteen beta-lactam antibiotics and fosfomycin.
Schröter G; Strobel I
Eur J Clin Microbiol; 1983 Dec; 2(6):608-9. PubMed ID: 6365541
[No Abstract] [Full Text] [Related]
5. In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Nasu M; Maskell JP; Williams RJ; Williams JD
Antimicrob Agents Chemother; 1981 Oct; 20(4):433-6. PubMed ID: 6282191
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1984 Dec; 26(6):947-8. PubMed ID: 6395802
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Eikenella corrodens to antimicrobial agents.
Sofianou D; Kolokotronis A
J Chemother; 1990 Jun; 2(3):156-8. PubMed ID: 2199625
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
Tweardy DJ; Jacobs MR; Speck WT
J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
[TBL] [Abstract][Full Text] [Related]
9. Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens.
Goldstein EJ; Cherubin CE; Shulman M
Antimicrob Agents Chemother; 1983 Jan; 23(1):42-5. PubMed ID: 6338819
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Bacteroides corrodens and Eikenella corrodens to ten chemotherapeutic agents.
Robinson JV; James AL
Antimicrob Agents Chemother; 1974 Nov; 6(5):543-6. PubMed ID: 15825302
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Thompson RL; Fisher KA; Wenzel RP
Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
Rolfe RD; Finegold SM
Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Eikenella corrodens to newer and older quinolones.
Goldstein EJ; Citron DM; Vagvolgyi AE; Gombert ME
Antimicrob Agents Chemother; 1986 Jul; 30(1):172-3. PubMed ID: 3530124
[TBL] [Abstract][Full Text] [Related]
15. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
16. [Activity of 14 antimicrobials against Eikenella corrodens].
Vay C; Almuzara M; Barberis C; Rodriguez C; Togneri A; Mattera J; Famiglietti A
Rev Argent Microbiol; 2002; 34(4):230-4. PubMed ID: 12600009
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
Jacobs MR; Kelly F; Speck WT
Antimicrob Agents Chemother; 1982 Nov; 22(5):897-900. PubMed ID: 6758692
[TBL] [Abstract][Full Text] [Related]
18. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Prince AS; Neu HC
Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin.
Ward JI; Moellering RC
Antimicrob Agents Chemother; 1981 Aug; 20(2):204-7. PubMed ID: 6912777
[TBL] [Abstract][Full Text] [Related]
20. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
